Chiusura precedente | 1,2300 |
Aperto | 1,2300 |
Denaro | 1,2300 x 200 |
Lettera | 1,2800 x 200 |
Min-Max giorno | 1,2400 - 1,3000 |
Intervallo di 52 settimane | 1,2000 - 7,1300 |
Volume | |
Media Volume | 668.169 |
Capitalizzazione | 8,462M |
Beta (5 anni mensile) | 61,68 |
Rapporto PE (ttm) | N/D |
EPS (ttm) | -3,4200 |
Prossima data utili | 12 mag 2024 - 16 mag 2024 |
Rendimento e dividendo (futuro) | N/D (N/D) |
Data ex dividendo | N/D |
Stima target 1A | 10,50 |
MELVILLE, NY., Oct. 09, 2023 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc. (the “Company” or “BioRetorative”) (NASDAQ: BRTX), a clinical stage company focused on stem cell-based therapies, announced today that Company CEO, Lance Alstodt, has been invited to present at the ROTH MKM Healthcare Opportunities Conference. Company BioRestorative Therapies, Inc.Presenter Lance Alstodt, Chief Executive OfficerDate & Time Thursday October 12th, 9:00am estLocation Yale Club, 50 Vanderbilt Avenue, NYC
--BioRestorative to Leverage its Core Competencies in Cell Biology and Manufacturing to Supply Biologics for Cosmetic Applications in Strategic Agreement --Agreement Represents Initial Venture into the $62.8 Billion Global Aesthetics Market --Initial Order of 5,000 Vials of Product Represents Controlled Launch and Will Have Positive Financial Impact MELVILLE, N.Y., Sept. 12, 2023 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ), a cl
--Site activation allows for patients in the State of New York to participate in the BRTX-100 trial— --15 Clinical Sites Identified, 12 of the 15 Activated and Recruiting Subjects MELVILLE, N.Y., Sept. 08, 2023 (GLOBE NEWSWIRE) -- BioRestorative Therapies, Inc . (“BioRestorative”, “BRTX” or the “Company”) (NASDAQ: BRTX ) , a clinical stage company focused on stem cell-based therapies, today announced that Northwell Health, New York State's largest health care provider, has been activated and can